Logo image of CHSCM

CHS INC - CHSINC 6 3/4 PERP (CHSCM) Stock Fundamental Analysis

USA - NASDAQ:CHSCM - US12542R7044

25.04 USD
+0.08 (+0.32%)
Last: 10/3/2025, 8:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CHSCM. CHSCM was compared to 89 industry peers in the Food Products industry. While CHSCM is still in line with the averages on profitability rating, there are concerns on its financial health. CHSCM has a expensive valuation and it also scores bad on growth. Finally CHSCM also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CHSCM had a positive operating cash flow in the past year.
Each year in the past 5 years CHSCM has been profitable.
Each year in the past 5 years CHSCM had a positive operating cash flow.
CHSCM Yearly Net Income VS EBIT VS OCF VS FCFCHSCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

1.2 Ratios

CHSCM has a Return On Assets of 2.61%. This is comparable to the rest of the industry: CHSCM outperforms 57.30% of its industry peers.
Looking at the Return On Equity, with a value of 4.76%, CHSCM is in line with its industry, outperforming 52.81% of the companies in the same industry.
The Return On Invested Capital of CHSCM (0.05%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CHSCM is significantly below the industry average of 27.78%.
The 3 year average ROIC (6.11%) for CHSCM is well above the current ROIC(0.05%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROIC 0.05%
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
CHSCM Yearly ROA, ROE, ROICCHSCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 1.42%, CHSCM perfoms like the industry average, outperforming 49.44% of the companies in the same industry.
In the last couple of years the Profit Margin of CHSCM has grown nicely.
CHSCM has a Operating Margin (0.02%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CHSCM has declined.
CHSCM's Gross Margin of 2.99% is on the low side compared to the rest of the industry. CHSCM is outperformed by 85.39% of its industry peers.
CHSCM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
CHSCM Yearly Profit, Operating, Gross MarginsCHSCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1 2 3 4 5

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHSCM is creating some value.
Compared to 1 year ago, CHSCM has a worse debt to assets ratio.
CHSCM Yearly Shares OutstandingCHSCM Yearly Shares OutstandingYearly Shares Outstanding 2018 2M 4M 6M 8M 10M
CHSCM Yearly Total Debt VS Total AssetsCHSCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.22 indicates that CHSCM is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CHSCM (2.22) is comparable to the rest of the industry.
CHSCM has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.34, CHSCM is doing good in the industry, outperforming 62.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACC0.01
WACC4.69%
CHSCM Yearly LT Debt VS Equity VS FCFCHSCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

CHSCM has a Current Ratio of 1.40. This is a normal value and indicates that CHSCM is financially healthy and should not expect problems in meeting its short term obligations.
CHSCM has a Current ratio (1.40) which is in line with its industry peers.
CHSCM has a Quick Ratio of 1.40. This is a bad value and indicates that CHSCM is not financially healthy enough and could expect problems in meeting its short term obligations.
CHSCM has a Quick ratio (0.86) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.4
Quick Ratio 0.86
CHSCM Yearly Current Assets VS Current LiabilitesCHSCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

1

3. Growth

3.1 Past

The Revenue has decreased by -8.96% in the past year.
CHSCM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.24% yearly.
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHSCM Yearly Revenue VS EstimatesCHSCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1

4. Valuation

4.1 Price/Earnings Ratio

Industry RankSector Rank
PE N/A
Fwd PE N/A
CHSCM Price Earnings VS Forward Price EarningsCHSCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHSCM is valued cheaper than 93.26% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.75
CHSCM Per share dataCHSCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 500 1K 1.5K 2K 2.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

7

5. Dividend

5.1 Amount

CHSCM has a Yearly Dividend Yield of 6.75%, which is a nice return.
Compared to an average industry Dividend Yield of 5.01, CHSCM pays a better dividend. On top of this CHSCM pays more dividend than 88.76% of the companies listed in the same industry.
CHSCM's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 6.75%

5.2 History

CHSCM has been paying a dividend for at least 10 years, so it has a reliable track record.
CHSCM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
CHSCM Yearly Dividends per shareCHSCM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

CHSCM pays out 32.94% of its income as dividend. This is a sustainable payout ratio.
DP32.94%
EPS Next 2YN/A
EPS Next 3YN/A
CHSCM Yearly Income VS Free CF VS DividendCHSCM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B
CHSCM Dividend Payout.CHSCM Dividend Payout, showing the Payout Ratio.CHSCM Dividend Payout.PayoutRetained Earnings

CHS INC - CHSINC 6 3/4 PERP

NASDAQ:CHSCM (10/3/2025, 8:00:00 PM)

25.04

+0.08 (+0.32%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)07-09 2025-07-09
Earnings (Next)11-04 2025-11-04
Inst Owners11.67%
Inst Owner Change-22.14%
Ins Owners0.03%
Ins Owner Change0%
Market Cap307.24M
Analysts0
Price TargetN/A
Short Float %0.1%
Short Ratio0.47
Dividend
Industry RankSector Rank
Dividend Yield 6.75%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP32.94%
Div Incr Years0
Div Non Decr Years4
Ex-Date09-16 2025-09-16 (0.421875)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.64
P/B 0.03
P/tB 0.03
EV/EBITDA 3.75
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-26.32
FCFYN/A
OCF(TTM)38.96
OCFY155.58%
SpS2936.43
BVpS878.97
TBVpS878.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.61%
ROE 4.76%
ROCE 0.07%
ROIC 0.05%
ROICexc 0.05%
ROICexgc 0.05%
OM 0.02%
PM (TTM) 1.42%
GM 2.99%
FCFM N/A
ROA(3y)8.28%
ROA(5y)6.12%
ROE(3y)15.4%
ROE(5y)11.43%
ROIC(3y)6.11%
ROIC(5y)4.27%
ROICexc(3y)6.66%
ROICexc(5y)4.61%
ROICexgc(3y)6.79%
ROICexgc(5y)4.69%
ROCE(3y)8.06%
ROCE(5y)5.71%
ROICexcg growth 3Y38.36%
ROICexcg growth 5Y-3.28%
ROICexc growth 3Y37.82%
ROICexc growth 5Y-3.23%
OM growth 3Y40.55%
OM growth 5Y-6.01%
PM growth 3Y24.89%
PM growth 5Y1.53%
GM growth 3Y21.71%
GM growth 5Y0.55%
F-Score3
Asset Turnover1.83
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 5.94
Cap/Depr 131.31%
Cap/Sales 2.22%
Interest Coverage 250
Cash Conversion 77.22%
Profit Quality N/A
Current Ratio 1.4
Quick Ratio 0.86
Altman-Z 2.22
F-Score3
WACC4.69%
ROIC/WACC0.01
Cap/Depr(3y)104.21%
Cap/Depr(5y)89.6%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.27%
Profit Quality(3y)93.36%
Profit Quality(5y)103.6%
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-8.96%
Revenue growth 3Y0.7%
Revenue growth 5Y4.24%
Sales Q2Q%1.63%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-98.83%
EBIT growth 3Y41.53%
EBIT growth 5Y-2.03%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-109.49%
FCF growth 3Y1.79%
FCF growth 5Y-7.81%
OCF growth 1Y-87.82%
OCF growth 3Y18.88%
OCF growth 5Y2.23%